Regulatory

Regulatory Information Management: What RIM Actually Needs to Cover

Somewhere in most regulatory affairs departments there is a spreadsheet that everyone is a little afraid of. It has a tab per market, or per product, or both. It has cells colored by someone's private convention for "submitted," "under review," and "approved." And it is the closest thing the company has to a single source of truth for what has actually been registered where.

That spreadsheet worked for a while. This is about the point where it stops, and what a proper regulatory information management system needs to do instead.

What regulatory information management actually covers

Regulatory information management, RIM, is the practice of keeping one current, structured record of everything a company has told health authorities about its products, and everything it still owes them. That includes product registrations by market, the status of every submission in flight, post-approval commitments made at the time of approval, variations filed against an existing registration, the labeling versions actually in force in each market, and the correspondence trail with each authority.

None of that is new information. Every company already has it, scattered across submission folders, email threads, and a regulatory affairs manager's memory. RIM is the decision to treat that information as a system of record rather than as institutional knowledge that leaves when the person holding it does. It is one part of a wider set of R&D and regulatory solutions that regulatory affairs teams increasingly expect to work together rather than as separate tools.

The core data a RIM system has to hold

Strip away the software and RIM is really six kinds of record, tracked consistently across every product and market:

  • Product registrations. What is approved, where, under what registration number, with what expiry or renewal date.
  • Submissions in progress. New applications, their current stage, and the dates that matter: submitted, queried, responded, approved or rejected.
  • Post-approval commitments. Anything promised to an authority at approval time that has to be delivered later, such as an additional stability time point or a follow-up study.
  • Variations. Every post-approval change filed against a registration, its classification, and whether it was approved before or required after implementation.
  • Labeling. Which version of the label and package insert is actually in force in each market, since these frequently drift out of sync across markets that approved changes at different times.
  • Correspondence. Every letter, query, and response exchanged with each authority, tied back to the registration or submission it concerns.

The common thread across all six is that they are relationships, not documents: a registration relates a product to a market and a date; a variation relates a change to a registration and a classification. A folder structure captures documents well. It does not capture relationships at all, which is exactly where the trouble starts.

Where spreadsheets and shared drives break down

The multiplication problem

A company with five products in three markets has fifteen registration records to track. Add a sixth product or a fourth market and the number does not grow by one column; it grows by every combination that column touches. Somewhere past a few dozen active registrations, the spreadsheet stops being a record and becomes a full-time reconciliation job, usually done by whoever happens to remember to update it.

The audit-trail problem

A spreadsheet cell that changes from "submitted" to "approved" does not say who changed it, when, or on what basis. When an inspector or an internal auditor asks how a specific variation was classified and who approved filing it, "the spreadsheet says so" is not an answer that holds up. A proper record needs the same thing a lab record needs: who did what, when, and why, kept automatically rather than as an afterthought.

Most dossier variations do not start in regulatory affairs. They start on the quality side, as a change control record: a new raw material supplier, a tightened in-process specification, a different manufacturing site. Our own change control module tracks exactly that kind of change through impact assessment, approval, and implementation.

The gap that causes real problems is what happens between "the change was approved and implemented" and "the corresponding variation was actually filed." If those two systems do not talk to each other, a plant can legitimately finish a change control record while the regulatory filing it was supposed to trigger sits untouched, sometimes for months. Linking change control to RIM means a quality change that affects a registered product creates a visible, trackable regulatory action instead of a silent gap between what the plant does and what the dossier says.

The other direction matters just as much. A submission or variation in RIM is only as good as the underlying chemistry, manufacturing, and controls data supporting it: the formulation record, the stability program, the validated analytical method. When RIM sits apart from the R&D systems that generate that data, regulatory affairs ends up re-keying information that already exists somewhere else, and the two versions inevitably drift apart over time.

This is the case for treating RIM as part of the same platform as R&D and regulatory affairs rather than as a bolt-on tracker. Our regulatory information management software keeps dossier compilation, registration tracking, renewal alerts, and correspondence tracking with authorities in the same system as the formulation, analysis, and stability data those filings are actually built on.

What actually matters when you evaluate a RIM system

Set aside the feature list for a moment and ask a narrower set of questions. Can it show, for any single product, every market it is registered in and the status of each, on one screen, without anyone compiling it by hand. Does every status change carry a date, a user, and a reason, automatically. Can a variation record link both backward to the change control record that triggered it and forward to the CTD sections it affects. And does it warn someone before a renewal or a commitment deadline arrives rather than after.

If the answer to all four is yes, the rest (dashboards, reporting, interface polish) is a real but secondary consideration. If the answer to any of them is no, that gap is exactly where the next missed renewal or unfiled variation will come from.

Frequently asked questions

What is regulatory information management (RIM)?

RIM is the discipline, and the software category, that keeps a single, current record of everything a company has told health authorities about its products: registrations by market, submissions and their status, post-approval commitments, variations, labeling versions, and the correspondence trail with each authority. The goal is one place that answers "what is currently approved, where, and what do we still owe the authority" without anyone having to phone around.

Is RIM the same thing as a document management system?

No, though the two overlap. A document management system stores and version-controls files. RIM is built around the registration and submission as the unit of record, with status, dates, and relationships between products, markets, and dossier sections. Documents live inside that structure, but RIM's job is tracking what has to happen and by when, not just where a file is stored.

At what size does a company actually need RIM software instead of spreadsheets?

There is no fixed headcount threshold. The signal is usually the number of active registration and market combinations crossing a point where one person can no longer hold the full picture from memory, or where a missed renewal or overdue commitment has already happened once. For a company with products registered in a handful of markets, a well-kept spreadsheet can genuinely work for a while. Past that, the coordination cost of spreadsheets tends to grow faster than the team does.

Why does RIM need to connect to QMS change control specifically?

Because most dossier variations start as a quality change: a new supplier, a tightened specification, a different manufacturing site. If change control and RIM are two separate systems with no link between them, a change can be approved and implemented on the quality side while the regulatory filing that was supposed to accompany it never gets tracked to completion. Connecting the two closes that gap by making the regulatory filing an explicit, visible step in the change record.

Does RIM replace regulatory affairs staff or just support them?

It supports them. RIM does not decide what to file or how to classify a variation; that judgment stays with regulatory affairs. What it removes is the manual tracking overhead: remembering which of forty registrations has a renewal due, reconciling three different spreadsheets that disagree, and chasing colleagues for a correspondence file that only exists in someone's inbox.

CORPEX Informatics

Enterprise software solutions for pharmaceutical, food, chemical, and manufacturing industries. Headquartered in Egypt, serving regulated industries across the MENA region since 2006.

Still tracking registrations in a spreadsheet?

See how RENOVA-RDX keeps registrations, submissions, and correspondence in the same system as the R&D data behind them.

See RENOVA-RDX for Regulatory Affairs